Michael Seth Altman - 13 Jun 2024 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Reporting relationship: Director
Issuer ticker: LYRA
Reported as of: 13 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jun 2024, 16:10:10 UTC
Prior SEC filing: 11 Jun 2024
Next SEC filing: 17 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Jason Cavalier, Attorney-in-Fact for Michael Seth Altman

Key filing fact

Michael Seth Altman filed Form 4 for Lyra Therapeutics, Inc. (LYRA) on 14 Jun 2024.

Key facts

This page summarizes Michael Seth Altman's Form 4 filing for Lyra Therapeutics, Inc. (LYRA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Jun 2024, 16:10.

Change

Previous filing in this sequence was filed on 11 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LYRA transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +30,000
Change %
Price: $0.000000
Shares after: 30,000
Date: 13 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,000
Exercise price: $0.3100
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) and (ii) the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case, subject to the Non-Employee Director's continued service on the Board as a Non-Employee Director through such vesting date.